Double-blind, Placebo-controlled Study on Men With Lower Urinary Tract Symptoms to Assess Changes in Pressure Flow Study and in Molecular Profile of Prostatic Tissue After 12 Weeks Treatment With Tadalafil.
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 25 Oct 2017 Planned End Date changed from 1 Apr 2019 to 1 Jun 2019.
- 25 Oct 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Mar 2019.
- 10 Jun 2017 Biomarkers information updated